EASD-话题@MedSci

#EASD#

78篇内容 | 1585人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1534107, encodeId=fec5153410ed3, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=【关注2017EASD】TOSCA IT研究：磺脲与吡格列酮孰优孰劣？, objectType=article, longId=112534, objectId=c0db1125344f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0db1125344f, replyNumber=0, likeNumber=60, createdTime=2017-09-12, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0db1125344f, moduleTitle=【关注2017EASD】TOSCA IT研究：磺脲与吡格列酮孰优孰劣？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0db1125344f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534106, encodeId=bfe91534106ed, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=EASD 2016：降糖治疗的1+1>2, objectType=article, longId=82111, objectId=59c08211114, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59c08211114, replyNumber=0, likeNumber=39, createdTime=2016-11-12, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59c08211114, moduleTitle=EASD 2016：降糖治疗的1+1>2, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59c08211114)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534105, encodeId=cae215341059e, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=EASD 2016：当糖尿病“邂逅”痴呆，防治新路在何方？, objectType=article, longId=82110, objectId=db45821100c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db45821100c, replyNumber=0, likeNumber=26, createdTime=2016-11-12, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db45821100c, moduleTitle=EASD 2016：当糖尿病“邂逅”痴呆，防治新路在何方？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db45821100c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534104, encodeId=ed551534104e3, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=EASD 2016：诺和诺德重磅降糖药Victoza显著降低心血管高危2型糖尿病患者肾脏损害进展, objectType=article, longId=78577, objectId=1b0ae8577af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b0ae8577af, replyNumber=0, likeNumber=29, createdTime=2016-09-28, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b0ae8577af, moduleTitle=EASD 2016：诺和诺德重磅降糖药Victoza显著降低心血管高危2型糖尿病患者肾脏损害进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b0ae8577af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534103, encodeId=a17e15341036f, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=EASD 2016：诺和诺德semaglutide使高危2型糖尿病患者主要心血管事件风险显著降低26%, objectType=article, longId=78355, objectId=803ae8355cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=803ae8355cc, replyNumber=0, likeNumber=42, createdTime=2016-09-26, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=803ae8355cc, moduleTitle=EASD 2016：诺和诺德semaglutide使高危2型糖尿病患者主要心血管事件风险显著降低26%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=803ae8355cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534102, encodeId=413d15341029d, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=EASD 2016：诺和诺德长效GLP-1降糖药semaglutide三大功效：降糖，减肥，降低心血管风险, objectType=article, longId=78310, objectId=11a0e8310ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11a0e8310ab, replyNumber=0, likeNumber=24, createdTime=2016-09-25, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11a0e8310ab, moduleTitle=EASD 2016：诺和诺德长效GLP-1降糖药semaglutide三大功效：降糖，减肥，降低心血管风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11a0e8310ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534101, encodeId=d3f015341018b, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压, objectType=article, longId=78308, objectId=7164e8308d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7164e8308d1, replyNumber=0, likeNumber=20, createdTime=2016-09-25, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7164e8308d1, moduleTitle=EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7164e8308d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534100, encodeId=74bb15341001a, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=EASD 2016：中国证据——糖尿病肾病基因位点新发现, objectType=article, longId=78197, objectId=ce12e8197f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce12e8197f0, replyNumber=0, likeNumber=46, createdTime=2016-09-24, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce12e8197f0, moduleTitle=EASD 2016：中国证据——糖尿病肾病基因位点新发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce12e8197f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534099, encodeId=a25c153409918, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=【2016EASD】糖尿病治疗药物的未来新希望, objectType=article, longId=78153, objectId=0553e815320, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0553e815320, replyNumber=0, likeNumber=46, createdTime=2016-09-23, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0553e815320, moduleTitle=【2016EASD】糖尿病治疗药物的未来新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0553e815320)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534098, encodeId=eaca153409861, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=EASD 2016：降低HbA1c，能减少血管并发症风险, objectType=article, longId=78044, objectId=f4afe8044b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4afe8044b2, replyNumber=0, likeNumber=39, createdTime=2016-09-22, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4afe8044b2, moduleTitle=EASD 2016：降低HbA1c，能减少血管并发症风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4afe8044b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534097, encodeId=9d6d153409e21, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=EASD研究速递——2型糖尿病与心血管疾病风险再探索, objectType=article, longId=77967, objectId=f358e7967c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f358e7967c1, replyNumber=0, likeNumber=40, createdTime=2016-09-22, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f358e7967c1, moduleTitle=EASD研究速递——2型糖尿病与心血管疾病风险再探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f358e7967c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534096, encodeId=294f153409626, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=【EASD 2016】闵科夫斯基奖：线粒体和能量转换对2型糖尿病的抵抗作用, objectType=article, longId=77893, objectId=9f46e789377, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f46e789377, replyNumber=0, likeNumber=22, createdTime=2016-09-21, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f46e789377, moduleTitle=【EASD 2016】闵科夫斯基奖：线粒体和能量转换对2型糖尿病的抵抗作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f46e789377)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534095, encodeId=7591153409550, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=EASD 2016：利拉鲁肽可有效延缓2型糖尿病进展, objectType=article, longId=77615, objectId=079fe7615f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=079fe7615f9, replyNumber=0, likeNumber=0, createdTime=2016-09-18, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=079fe7615f9, moduleTitle=EASD 2016：利拉鲁肽可有效延缓2型糖尿病进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=079fe7615f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534094, encodeId=cd68153409493, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=EASD 2016：孕妇在夏天更容易患妊娠期糖尿病？, objectType=article, longId=77614, objectId=97bde7614e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97bde7614e4, replyNumber=0, likeNumber=30, createdTime=2016-09-18, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97bde7614e4, moduleTitle=EASD 2016：孕妇在夏天更容易患妊娠期糖尿病？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97bde7614e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534093, encodeId=7e6a153409371, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=EASD 2016：2型糖尿病患者的抑郁比例很高, objectType=article, longId=77613, objectId=029ee761326, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=029ee761326, replyNumber=0, likeNumber=33, createdTime=2016-09-17, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=029ee761326, moduleTitle=EASD 2016：2型糖尿病患者的抑郁比例很高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=029ee761326)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534092, encodeId=c8f11534092bd, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=EASD 2016：新发糖尿病？警惕胰腺癌！, objectType=article, longId=77612, objectId=0c78e76129b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c78e76129b, replyNumber=0, likeNumber=42, createdTime=2016-09-17, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c78e76129b, moduleTitle=EASD 2016：新发糖尿病？警惕胰腺癌！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c78e76129b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534091, encodeId=10bc1534091ab, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=EASD 2016：震惊！多不饱和脂肪酸摄入过多，竟然会增加2型糖尿病风险！, objectType=article, longId=77611, objectId=25e0e7611ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25e0e7611ca, replyNumber=0, likeNumber=41, createdTime=2016-09-17, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25e0e7611ca, moduleTitle=EASD 2016：震惊！多不饱和脂肪酸摄入过多，竟然会增加2型糖尿病风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25e0e7611ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534090, encodeId=0a31153409023, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=EASD 2015：世界上年轻的2型糖尿病患者只有3岁！, objectType=article, longId=56455, objectId=219c564551a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=219c564551a, replyNumber=0, likeNumber=29, createdTime=2015-09-24, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=219c564551a, moduleTitle=EASD 2015：世界上年轻的2型糖尿病患者只有3岁！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=219c564551a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534089, encodeId=2e8e1534089ab, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=专家解读2015ADA/EASD高血糖管理立场声明, objectType=article, longId=48398, objectId=ad9b48398ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad9b48398ed, replyNumber=0, likeNumber=16, createdTime=2015-03-21, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad9b48398ed, moduleTitle=专家解读2015ADA/EASD高血糖管理立场声明, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad9b48398ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1534088, encodeId=383d1534088ef, content=<a href='/topic/show?id=576e643634' target=_blank style='color:#2F92EE;'>#EASD#</a>, objectTitle=ADA和EASD联合发布：全新2型糖尿病管理指南, objectType=article, longId=46597, objectId=56ac4659ead, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56ac4659ead, replyNumber=0, likeNumber=41, createdTime=2015-02-05, rootId=0, userName=qilu_qi, userId=21f812527653, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56ac4659ead, moduleTitle=ADA和EASD联合发布：全新2型糖尿病管理指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56ac4659ead)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EASD

2020-05-29

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

【关注2017EASD】TOSCA IT研究：磺脲与吡格列酮孰优孰劣？

2017-09-12

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

EASD 2016：降糖治疗的1+1>2

2016-11-12

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

EASD 2016：当糖尿病“邂逅”痴呆，防治新路在何方？

2016-11-12

智慧医人 (审核中...)

前往app查看评论内容

#EASD#

EASD 2016：诺和诺德重磅降糖药Victoza显著降低心血管高危2型糖尿病患者肾脏损害进展

2016-09-28

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

EASD 2016：诺和诺德semaglutide使高危2型糖尿病患者主要心血管事件风险显著降低26%

2016-09-26

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

EASD 2016：诺和诺德长效GLP-1降糖药semaglutide三大功效：降糖，减肥，降低心血管风险

2016-09-25

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

EASD 2016：阿斯利康2型糖尿病组合疗法Bydureon/Forxiga（GLP-1RA/SGLT-2i）III期临床显著降低血糖水平、体重、收缩压

2016-09-25

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

EASD 2016：中国证据——糖尿病肾病基因位点新发现

2016-09-24

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

【2016EASD】糖尿病治疗药物的未来新希望

2016-09-23

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

EASD 2016：降低HbA1c，能减少血管并发症风险

2016-09-22

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

EASD研究速递——2型糖尿病与心血管疾病风险再探索

2016-09-22

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

【EASD 2016】闵科夫斯基奖：线粒体和能量转换对2型糖尿病的抵抗作用

2016-09-21

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

EASD 2016：利拉鲁肽可有效延缓2型糖尿病进展

2016-09-18

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

EASD 2016：孕妇在夏天更容易患妊娠期糖尿病？

2016-09-18

hb2008ye (审核中...)

前往app查看评论内容

#EASD#

EASD 2016：2型糖尿病患者的抑郁比例很高

2016-09-17

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

EASD 2016：新发糖尿病？警惕胰腺癌！

2016-09-17

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

EASD 2016：震惊！多不饱和脂肪酸摄入过多，竟然会增加2型糖尿病风险！

2016-09-17

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

EASD 2015：世界上年轻的2型糖尿病患者只有3岁！

2015-09-24

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

专家解读2015ADA/EASD高血糖管理立场声明

2015-03-21

qilu_qi (审核中...)

前往app查看评论内容

#EASD#

ADA和EASD联合发布：全新2型糖尿病管理指南

2015-02-05

科室
- - 订阅+
  - 更多科室
工具
服务